Plazomicin in multidrug-resistant complicated urinary tract infections: a scoping review
This review underscores plazomicin as a promising treatment for MDR cUTIs. However, limited data from low- and middle-income countries like India highlight the need for real-world studies on its efficacy, safety, and cost-effectiveness in such countries.
Authors
- Senthur P Nambi
- Rohit Malabade (ORCID: https://orcid.org/0000-0002-9575-3018)
- Subhash Kumar Todi (ORCID: https://orcid.org/0000-0003-2306-6080)
- Rajeev N. Soman (ORCID: https://orcid.org/0000-0003-1578-9932)
- Vaishali Gupte (ORCID: https://orcid.org/0000-0003-4439-2416)
- Balaji Veeraraghavan (ORCID: https://orcid.org/0000-0002-8662-4257)
- J Gogtay
- Sanjay Pandey
- Yatin Mehta
- Senthilnathan Mohanasundaram (ORCID: https://orcid.org/0000-0001-8615-6695)
- V. Ramasubramanian
Institutions
- Medanta The Medicity (IN)
- Apollo Hospitals (IN)
- Christian Medical College, Vellore (IN)
- Christian Medical College (IN)
- Medanta The Medicity (IN)
- Apollo Hospitals (IN)
- Kokilaben Dhirubhai Ambani Hospital (IN)
- Cipla (India) (IN)
- Apollo Hospitals (IN)
- AMRI Hospitals (IN)
Publication Details
- Journal
- Therapeutic Advances in Infectious Disease
- Published
- 2025-12-01
- DOI
- https://doi.org/10.1177/20499361251401104
- Primary Topic
- Urinary Tract Infections Management
- Type
- article
- Field-Weighted Citation Impact
- 0.00